Related Experiment Video

Updated: Jun 28, 2025

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
07:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

2.6K

Harnessing Antitumor Immunity in Ovarian Cancer

Katherine C Kurnit1, Kunle Odunsi2,3

  • 1Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois 60637, USA.

Cold Spring Harbor Perspectives in Medicine
|April 15, 2024
PubMed

Insights

Immunotherapy shows limited success in high-grade serous ovarian cancer despite T cell presence. Understanding immune resistance mechanisms is key to improving patient responses to immunotherapy agents.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Immunotherapy is a standard treatment for many cancers, but not yet for high-grade serous ovarian cancer.
  • T cell infiltration is common in ovarian cancer, yet clinical responses to immunotherapy are low.
  • Investigating immune resistance mechanisms is crucial for advancing ovarian cancer treatment.

Purpose of the Study:

  • To review the current understanding of the ovarian cancer immune landscape.
  • To analyze existing data on immunotherapy strategies for ovarian cancer patients.
  • To explore potential future directions for improving immunotherapy efficacy.

Main Methods:

  • Literature review of the ovarian cancer immune microenvironment.
  • Analysis of clinical trial data for immunotherapy in ovarian cancer.
  • Synthesis of current research to identify challenges and opportunities.

Main Results:

  • Ovarian cancer presents a complex immune landscape with significant barriers to immunotherapy.
  • Despite T cell infiltration, intrinsic and extrinsic factors contribute to immune evasion.
  • Current immunotherapy approaches have shown limited efficacy in this patient population.

Conclusions:

  • Further research into ovarian cancer's immune resistance is essential.
  • Novel therapeutic strategies are needed to enhance immunotherapy response.
  • Targeting specific immune pathways may improve outcomes for ovarian cancer patients.

More Related Videos

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

13.8K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.6K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K